One in eight Americans are now on the obesity drugs that have become known generally as GLP-1s and sold specifically under names like Ozempic, Wegovy, Mounjaro and Zepbound
For my patients in Lafayette, the Bay Area, or anywhere in California via telemedicine , this discussion is simplified and clarified so your questions, anxiety and fear are resolved with the right science
This product is supplied exclusively for research, laboratory, and in-vitro study by qualified professionals
In cases of overweight or less severe obesity, 30% body weight loss may be an unnecessary or even harmful treatment target
However, it is crucial to understand that this formulation is not a substitute for any other treatments prescribed by a healthcare provider
Trends in Formulation eBook